We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ASMB market cap is 70.23M. The company's latest EPS is USD -11.1673 and P/E is -1.15.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.4M | -24.74M | -19.56M | -17.49M | -15.05M |
| Net Income | -23.15M | -22.4M | -18.95M | -16.9M | -14.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 15.96M | 79.11M | 6.25M | 0 | 7.16M |
| Operating Income | -102.71M | -64.08M | -132.69M | -94.11M | -64.65M |
| Net Income | -97.63M | -62.15M | -129.86M | -93.09M | -61.23M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 121.52M | 101.79M | 83.12M | 66.58M | 51.63M |
| Total Liabilities | 19.11M | 19.13M | 12.78M | 11.63M | 9.92M |
| Total Equity | 102.4M | 82.66M | 70.33M | 54.95M | 41.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 339.91M | 283.25M | 191.06M | 101.79M | 136.82M |
| Total Liabilities | 66.69M | 42.68M | 22.13M | 19.13M | 95.73M |
| Total Equity | 273.22M | 240.58M | 168.93M | 82.66M | 41.1M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -65.21M | -84.46M | -23.43M | -37.06M | -50.9M |
| Investing | 74.08M | 90.64M | 10M | 1.64M | 20.52M |
| Financing | 177k | 614k | 4.49M | 4.63M | 4.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -84.07M | -62.96M | -93.4M | -84.46M | 22.74M |
| Investing | -50.32M | 68.07M | 26.52M | 90.64M | -69.14M |
| Financing | 139.65M | 7.6M | 53.06M | 614k | 13.82M |
| Market Cap | 70.23M |
| Price to Earnings Ratio | -1.15 |
| Price to Sales Ratio | 9.8 |
| Price to Cash Ratio | 3.54 |
| Price to Book Ratio | 1.71 |
| Dividend Yield | - |
| Shares Outstanding | 5.48M |
| Average Volume (1 week) | 16.87k |
| Average Volume (1 Month) | 15.21k |
| 52 Week Change | 6.75% |
| 52 Week High | 20.04 |
| 52 Week Low | 7.692 |
| Spread (Intraday) | 0.86 (6.43%) |
| Company Name | Assembly Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.assemblybio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
